Navigation Links
International Diabetes Federation Grant Supports Lifestyle Intervention Study to Prevent Type 2 Diabetes in India
Date:5/30/2008

BRUSSELS and ATLANTA, Georgia, May 30 /PRNewswire/ -- The International Diabetes Federation (IDF) BRIDGES translational research grant programme will fund a lifestyle intervention trial that seeks to reduce the risk of for people developing type 2 diabetes in Chennai, India.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080602/306819 )

The community based diabetes prevention programme will determine optimal ways to translate the programs developed for research studies of lifestyle interventions for diabetes prevention to real-life settings in Chennai (formerly Madras) India. The Rollins School of Public Health at Emory University will collaborate with a team of investigators from Madras Diabetes Research Foundation (MDRF) and will facilitate a study of 700 people with pre-diabetes in Chennai. The study is designed to explore ways to identify and evaluate culturally appropriate, low-cost, feasible and sustainable ways to promote changes in health behaviours, improved diet, weight loss and increased physical activity to prevent diabetes in those in South India.

The messages will be tailored to the unique dietary patterns and physical activity programmes of Indian communities and will be designed to determine if these targeted interventions are effective and cost-effective.

"This grant will help researchers and clinicians to better understand how to create and deliver culturally tailored programs for the prevention of diabetes in high-risk populations. The project is designed to produce a permanent, community-based program for promoting diabetes prevention and healthy lifestyle changes" said Dr. K.M. Venkat Narayan, principal investigator of the study and a world leader in translational research.

The International Diabetes Federation's Diabetes Atlas reports that India has the highest number of people with diabetes in the world. Currently, 40.9 milli
'/>"/>

SOURCE International Diabetes Federation (IDF)
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
3. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
6. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
7. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
11. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...COTTSDALE, Ariz., Nov. 30 /PRNewswire-FirstCall/ -...er of radiology solutions to radiology groups and ...ented a redesigned Quality Assurance (QA) program ... radiologists and customers and to deliver superio...g an overview of the new QA program in several pre...
(Date:11/30/2009)... NEW YORK, Nov. 30 Reportlinker.co...vailable in its catalogue: ,, Outsourcing Oppo..., http://www.reportlinker.com/p0165747/Outsourci..., Report Description ,, Medical devices form on...ith an estimated size of $250 billion in 2009 and ...
(Date:11/30/2009)...UREL, N.J., Nov. 30 ... of technology-enabled clinical documentation serv... Radiological Society of North America (RSNA) conf...logy, the product leverages SpeechQ(TM), the compa...ication used by thousands of radiologists. MedQui...
Breaking Medicine Technology:NightHawk Radiology Launches Redesigned Quality Assurance Program 2Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 2Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 3Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 4Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 5Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 6Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 7Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 8Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 9MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 2Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 1Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 2Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 3Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 4Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 5Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 6Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 7Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 8Athera Receives Allowance of Two Key Patents 14468 1Athera Receives Allowance of Two Key Patents 14468 2Eastern Europes First Novalis Tx 28TM 29 Radiosurgery Platform Begins Radiotherapy Treatments in Latvia using RapidArc 28R 29 Technology 5467 1Eastern Europes First Novalis Tx 28TM 29 Radiosurgery Platform Begins Radiotherapy Treatments in Latvia using RapidArc 28R 29 Technology 5467 2Eastern Europes First Novalis Tx 28TM 29 Radiosurgery Platform Begins Radiotherapy Treatments in Latvia using RapidArc 28R 29 Technology 5467 3
...e,powers of testosterone, we usually do not consid...at testosterone levels may affect men,s,cognitive ...vard Men,s,Health Watch., All the body,s attribut...ception. Memory is the most fragile mental functio...on is processed less carefully, and,details often ...
... Traditional Approval -, YARDLEY, Pa., Dec. 21 T...pplemental New Drug Application (sNDA) to the U.S....se inhibitor (PI) PREZISTA(TM),(darunavir) tablets...,indication to include human immunodeficiency viru...lication includes 48-week data from two,Phase 3 st...
Other Medicine Technology:Testosterone May Improve Mental Function, From the Harvard Men's Health Watch 2Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 2Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 3Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 4Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 5
(Date:12/1/2009)...or Not helps families prepare for and embrace cari...nnati, Ohio (PRWEB) December 2, 2009 -- Charles Pu...ies understand and embrace the challenges of careg...s live long, healthy and prosperous lives, the rea...t, and their needs often become evident during the...
(Date:12/1/2009)...will be given by Estes Audiology to worthy recipie...ustin, TX (PRWEB) December 1, 2009 -- Estes Audiol...ing healthcare provider dedicated to improving the... announced today the beginning of its “Gift ...tes Audiology donates two pairs of hearing aids in...
(Date:12/1/2009)... MD was elected to the Stemedica Cell Technologies...s at the Company’s November 20th Board Meeti... 2009 -- Anthony M. Marlon, MD was elected to the ...ica”) Board of Directors at the Company&rsqu...D, Executive Chairman for Stemedica made the annou...
(Date:12/1/2009)... To date, hospitals have not found ...or the $20 cost of the disposable sensor for your ... Anesthesiologists have not told hospitals how imp...a from routine anesthesia over-medication. ,, A...dication, message from their leaders because their...
(Date:12/1/2009)...re-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Na...he 21st Annual Piper Jaffray Health Care Conferenc...e will be webcast live at www.celltherapeutics.co...lmes 1 at the New York Palace Hotel, and will also..., , Piper Jaffray Health Care...
Breaking Medicine News(10 mins):Health News:Aging Expert's New Book Helps Boomers Address Challenges of Caregiving 2Health News:Estes Audiology Offers the Gift of Hearing to Celebrate the Holiday Season 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 3Health News:5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed 2
...rsity School of Medicine reported that women who s...ften do not report their discomfort or seek medica...en they do report to their medical practitioner th...stimated to affect about one third of the adult wo...
...eived its first tentative approval from the US Foo.../ and market lamivudine tablets that can be used i...(ARVs) to treat patients with HIV infection. ...he other ARVs including the present lamivudine tab...
...yme’s new role in aiding joint inflammations in co...cathepsin G can regulate the ability of the immune...ocess of inflammatory conditions that can lead to ...nflammatory condition of arthritis. Researche...
...dwide suffer from Filarial infection and some// ge...their legs resemble that of an Elephant. The condi...crofti, this is a threadlike worm They go and hous...enitalia like the scrotum, penis or vulva. The...
...cover a new molecular structure that may be// used...sing stem cell technology. The research had l...t controls an important part of retinal cell diffe...chnology to create new retinal cells. Stem ...
...pe 1 or type 2 are at increased risk from having r...and skin infections. Some other problems tha...re kidney damage, nerve damage, eye problems that ...ns dealing with the disease currently know these. ...
Other Medicine News:Health News:Antibiotics help combat dangerous tropical disease 2
Donor Collet, 0.6 mm, Spare part for ATA100
Recipient Stylus, 2.0 mm, Spare part for ATA100
Pulley for Cable, Spare part for ATA100
Knife Raising Block
Medicine Products: